期刊文献+

白癜风患者外周血单一核细胞Toll样受体7、9mRNA表达的初步研究 被引量:4

Expressions of Toll-like receptor 7 and 9 mRNA in peripheral blood mononuclear cells from patients with vitiligo
原文传递
导出
摘要 目的探讨Toll样受体7、9(TLR7、TLR9)mRNA在白癜风患者外周血单一核细胞(PBMC)中的表达及其意义。方法应用实时荧光定量逆转录聚合酶链反应(RT—PCR)技术检测50例白癜风患者及25例正常人对照PBMC中TLR7、TLR9mRNA的表达。采用SPSS11.5软件进行统计学分析,两样本均数比较采用t检验。结果白癜风患者PBMC中TLR7mRNA(目的基因绝对定量校正拷贝数为0.85±1.90)、TLR9mRNA(0.94±2.25)表达均明显高于对照组(分别为0.44±1.18和0.11±0-31,P〈0.05和〈0.01);稳定期与进展期、局限型与泛发型白癜风患者TLR7、TLR9mRNA表达差异均无统计学意义(P值均〉0.05)。结论白癜风患者PBMC中TLR7、TLR9mRNA的表达均上调,TLR7、TLR9的异常表达可能参与白癜风的发病机制。 Objective To-detect the expressions of Toll-like receptor (TLR) 7 and 9 mRNA in peripheral blood mononuclear cells (PBMCs) from patients with vitiligo and their significance. Methods Real-time fluorescence-based quantitative reverse transcription-PCR was performed to detect the expressions of TLR7 and TLR9 mRNA in PBMCs from 50 patients with vitiligo and 25 normal human controls. Two-sample t test was conducted by using SPSS 11.5 software to compare the expression difference of TLR7 and TLR9 mRNA between the patients and controls. Results The mRNA expression level (the ratio of the absolute copy number of a target gene to a control gene) of TLR7 and TLR9 in PBMCs were significantly higher in patients with vitiligo than in the normal human controls (0.85 ± 1.90 vs. 0.44 ± 1.18, P 〈 0.05; 0.94 ± 2.25 vs. 0.11 ± 0.31, P 〈 0.01). No significant difference was observed in the expression level of TLR7 or TLR9 mRNA in PBMCs between patients with stable and active vitiligo, or between patients with localized and generalized vitiligo (both P 〉 0.05). Conclusions The expression level of TLR7 and TLR9 mRNA is elevated in PBMCs from patients with vitiligo, which may be involved in the pathogenesis of vitiligo.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2012年第4期249-251,共3页 Chinese Journal of Dermatology
基金 广州市医药卫生科技项目(2009-YB-140)
关键词 白癜风 TOLL样受体7 TOLL样受体9 Vitiligo Toll-like receptor 7 Toll-like receptor 9
  • 相关文献

参考文献10

  • 1Ruiz-Argtielles A, Brito GJ, Reyes-Izquierdo P, et al. Apoptosis of melanocytes in vitiligo results from antibody penetration. J Autoimmun, 2007, 29(4): 281-286.
  • 2张继玲,曹碧兰.白癜风免疫学说新进展[J].遵义医学院学报,2006,29(4):403-407. 被引量:8
  • 3Hurst J, von Landenberg P. Toll-like receptors and autoimmunity. Autoimmun Rev, 2008, 7 (3): 204-208.
  • 4Heil F, Hemmi H, Hochrein H, et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science, 2004, 303(5663): 1526-1529.
  • 5Ichikawa HT, Williams LP, Segal BM. Activation of APCs through CD40 or Toll-like receptor 9 overcomes tolerance and precipitates autoimmune disease. J Immunol, 2002, 169(5): 2781-2787.
  • 6尉雁,董琛,陈丽瑛.白癜风患者外周血单个核细胞IL-2 IL-10和IFN-γ的表达特点[J].山西医药杂志,2006,35(8):686-688. 被引量:4
  • 7Escobar A, Lrpez M, Serrano A, et al. Dendritic cell immunizations alone or combined with low doses of interleukin-2 "induce specific immune responses in melanoma patients. Clin Exp Immunol, 2005, 142(3): 555-568.
  • 8Gogas H, Ioannovich J, Dafni U, et al. Prognostic significance of autoimmunity during treatment of melanoma with interferon. N Engl J Med, 2006, 354(7): 709-718.
  • 9Fenton JS, Bergstrom KG. Vitiligo: nonsurgical treatment options and the evidence behind their Use. J Drugs Dermatol, 2008, 7(7): 705-711.
  • 10Tormo D, Ferrer A, Bosch P, et al. Therapeutic efficacy of antigen- specific vaccination and toll-like receptor stimulation against established transplanted and autochthonous melanoma in mice. Cancer Res, 2006, 66( 10): 5427-5435.

二级参考文献32

共引文献10

同被引文献35

  • 1陈鹏,蒋献.窄谱中波紫外线治疗皮肤病的作用机制[J].国际皮肤性病学杂志,2007,33(1):33-35. 被引量:26
  • 2Elkon KB, Sontheimer C. Editorial: toll-like receptor 7: more than skin deep? [ J ]. Arthritis Rheumatol, 2014, 66 ( 3 ): 481-484.
  • 3Matsushima N, Tanaka T, Enkhbayar P, et al. Comparative sequence analysis of leucine-rich repeats (LRRs) within vertebrate toll-like receptors [J]. BMC Genomies, 2007, 8: 124.
  • 4Yu N, Zhang S, Zuo F, et al. Cultured human melanocytes express functional toll-like receptors 2-4, 7 and 9 [J]. J Dermatol Sci, 2009, 56(2): 113-120.
  • 5Barrat FJ, Coffman RL. Development of TLR inhibitors for the treatment of autoimmune diseases [J]. Immunol Rev, 2008, 223: 271-283.
  • 6Guldueci C1, Gong M, Xu Z, et al. TLR recognition of self nueleie acids hampers glueocortieoid aetivity in lupus[J]. Nature, 2010, 465(7300): 937-941.
  • 7Ueyama A, Yamamoto M, Tsujii K, et al. Meehanism of pathogenesis of imiquimod-induced skin inflammation in the mouse: a role for interferon-alpha in dendritie eell aetivation by imiquimod[J]. J Dermatol, 2014, 41 (2): 135-143.
  • 8Bourgeois C, Majer O, Frohner IE, et al. Conventional dendritic ceils mount a type I IFN response against Candida spp. requiring novel phagosomal TLR7-mediated IFN-β signaling [J]. J Immunol, 2011, 186(5): 3104-3112.
  • 9Biondo C, Malara A, Costa A, et al. Recognition of fungal RNA by TLR7 has a nonredundant role in host defense against experimental eandidiasis [J]. Ear J Immunol, 2012, 42 (10): 2632-2643.
  • 10Eiro N, Ovies C, Fernandez-Garcia B, et al. Expression of TLR3, 4, 7 and 9 in cutaneous malignant melanoma: relationship with clinicopathological characteristics and prognosis [J]. Arch Dermatol Res, 2013, 305 ( 1 ): 59-67.

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部